Gene · 7408
Papers3,538
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
541 to 560 of 3,538
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| LINC00461 Regulates the Recurrence of Large B Cell Lymphoma through the miR-411-5p/BNIP3 Pathway. | Evid Based Complement Alternat Med | 2022 | 35783530 | PubTator, text mining | PubMed |
| Quantitative proteomic analysis of gingival crevicular fluids to identify novel biomarkers of gingival recession in orthodontic patients. | J Proteomics | 2022 | 35779762 | PubTator, text mining | PubMed |
| Tight Junctions, the Epithelial Barrier, and Toll-like Receptor-4 During Lung Injury. | Inflammation | 2022 | 35779195 | PubTator, text mining | PubMed |
| Protein tyrosine phosphatase PTPN22 negatively modulates platelet function and thrombus formation. | Blood | 2022 | 35767715 | PubTator, text mining | PubMed |
| Phostensin enables lymphocyte integrin activation and population of peripheral lymphoid organs. | J Exp Med | 2022 | 35766979 | PubTator, text mining | PubMed |
| Hypoxia-induced LncRNA DACT3-AS1 upregulates PKM2 to promote metastasis in hepatocellular carcinoma through the HDAC2/FOXA3 pathway. | Exp Mol Med | 2022 | 35764883 | PubTator, text mining | PubMed |
| Comparative effects of fentanyl versus morphine on platelet inhibition induced by ticagrelor in patients with ST-segment elevation myocardial infarction: Full results of the PERSEUS randomized trial. | Cardiol J | 2022 | 35762079 | PubTator, text mining | PubMed |
| The SKBR3 cell-membrane proteome reveals telltales of aberrant cancer cell proliferation and targets for precision medicine applications. | Sci Rep | 2022 | 35760832 | PubTator, text mining | PubMed |
| Ena/VASP Protein-Mediated Actin Polymerization Contributes to Naïve CD8+ T Cell Activation and Expansion by Promoting T Cell-APC Interactions In Vivo. | Front Immunol | 2022 | 35757762 | PubTator, text mining | PubMed |
| Impact of Prasugrel and Ticagrelor on Platelet Reactivity in Patients With Acute Coronary Syndrome: A Meta-Analysis. | Front Cardiovasc Med | 2022 | 35757353 | PubTator, text mining | PubMed |
| Vericiguat Modulates Osteoclast Differentiation and Bone Resorption via a Balance between VASP and NF-κB Pathways. | Mediators Inflamm | 2022 | 35757109 | PubTator, text mining | PubMed |
| Theoretical Studies of a Silica Functionalized Acrylamide for Calcium Scale Inhibition. | Polymers (Basel) | 2022 | 35745909 | PubTator, text mining | PubMed |
| Frustrated Lewis Pairs in Heterogeneous Catalysis: Theoretical Insights. | Molecules | 2022 | 35744860 | PubTator, text mining | PubMed |
| Single-cell analyses highlight the proinflammatory contribution of C1q-high monocytes to Behçet's disease. | Proc Natl Acad Sci U S A | 2022 | 35727985 | PubTator, text mining | PubMed |
| Mechanoautophagy: Synergies Between Autophagy and Cell Mechanotransduction at Adhesive Complexes. | Front Cell Dev Biol | 2022 | 35721483 | PubTator, text mining | PubMed |
| Powering morphogenesis: multiscale challenges at the interface of cell adhesion and the cytoskeleton. | Mol Biol Cell | 2022 | 35696393 | PubTator, text mining | PubMed |
| Quantitative phosphoproteomics reveal cellular responses from caffeine, coumarin and quercetin in treated HepG2 cells. | Toxicol Appl Pharmacol | 2022 | 35688186 | PubTator, text mining | PubMed |
| Increased Risk of COVID-19 in Patients with Diabetes Mellitus-Current Challenges in Pathophysiology, Treatment and Prevention. | Int J Environ Res Public Health | 2022 | 35682137 | PubTator, text mining | PubMed |
| Low platelet reactivity in patients with myocardial infarction treated with aspirin plus ticagrelor. | Einstein (Sao Paulo) | 2022 | 35674593 | PubTator, text mining | PubMed |
| Quantitative proteomics and in-cell cross-linking reveal cellular reorganisation during early neuronal differentiation of SH-SY5Y cells. | Commun Biol | 2022 | 35672350 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/7408/papers?page=28